4D Molecular Therapeutics enrolls first patients in Phase 3 4SIGHT trial of 4D-150 for DME

The global Phase 3 study is in treatment-naïve diabetic macular edema. The company also cited updated two-year SPECTRA results supporting durable vision and anatomical improvements.